Janney Montgomery Scott’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.5M Buy
2,334,351
+118,964
+5% +$3.17M 0.16% 137
2025
Q4
$55.2M Buy
2,215,387
+199,213
+10% +$5.02M 0.13% 168
2025
Q3
$51.4M Buy
+2,016,174
New +$49.8M 0.12% 165
2025
Q1
Sell
-2,453,989
Closed -$65.1M 2823
2024
Q4
$65.1M Sell
2,453,989
-366,688
-13% -$9.95M 0.18% 115
2024
Q3
$81.6M Buy
2,820,677
+143,347
+5% +$4.18M 0.23% 88
2024
Q2
$74.9M Buy
2,677,330
+163,017
+6% +$4.49M 0.23% 90
2024
Q1
$69.8M Buy
2,514,313
+28,797
+1% +$799K 0.21% 98
2023
Q4
$71.6M Sell
2,485,516
-128,149
-5% -$3.87M 0.23% 91
2023
Q3
$86.7M Sell
2,613,665
-96,723
-4% -$3.42M 0.32% 62
2023
Q2
$99.4M Buy
2,710,388
+47,807
+2% +$1.86M 0.35% 65
2023
Q1
$109M Sell
2,662,581
-14,465
-0.5% -$625K 0.44% 51
2022
Q4
$137M Buy
2,677,046
+87,860
+3% +$4.21M 0.53% 35
2022
Q3
$113M Buy
2,589,186
+79,364
+3% +$3.86M 0.49% 38
2022
Q2
$128M Buy
2,509,822
+51,923
+2% +$2.65M 0.58% 29
2022
Q1
$127M Buy
2,457,899
+54,633
+2% +$2.83M 0.54% 36
2021
Q4
$142M Buy
2,403,266
+48,473
+2% +$2.4M 0.55% 32
2021
Q3
$101M Buy
2,354,793
+1,592
+0.1% +$70.5K 0.43% 51
2021
Q2
$92.2M Sell
2,353,201
-66,485
-3% -$2.59M 0.41% 56
2021
Q1
$87.7M Buy
2,419,686
+23,669
+1% +$840K 0.43% 55
2020
Q4
$88.2M Buy
2,396,017
+36,230
+2% +$1.33M 0.43% 52
2020
Q3
$82.2M Buy
2,359,787
+11,520
+0.5% +$404K 0.47% 46
2020
Q2
$72.9M Sell
2,348,267
-169,738
-7% -$5.77M 0.46% 49
2020
Q1
$78M Buy
2,518,005
+187,053
+8% +$6.37M 0.62% 29
2019
Q4
$86.6M Buy
2,330,952
+121,657
+6% +$4.33M 0.57% 32
2019
Q3
$75.3M Buy
2,209,295
+73,891
+3% +$2.69M 0.55% 36
2019
Q2
$87.8M Buy
2,135,404
+101,582
+5% +$4.03M 0.67% 21
2019
Q1
$82M Buy
2,033,822
+35,634
+2% +$1.43M 0.67% 20
2018
Q4
$82.8M Sell
1,998,188
-126,206
-6% -$5.24M 0.8% 17
2018
Q3
$88.8M Sell
2,124,394
-1,739
-0.1% -$66.9K 0.76% 16
2018
Q2
$73.2M Sell
2,126,133
-65,870
-3% -$2.25M 0.7% 19
2018
Q1
$73.8M Buy
2,192,003
+165,996
+8% +$5.71M 0.74% 17
2017
Q4
$69.6M Buy
2,026,007
+78,272
+4% +$2.67M 0.72% 17
2017
Q3
$66M Buy
1,947,735
+48,531
+3% +$1.56M 0.75% 17
2017
Q2
$60.5M Buy
1,899,204
+1,032
+0.1% +$32.5K 0.76% 18
2017
Q1
$61.6M Buy
1,898,172
+195,681
+11% +$6.17M 0.82% 14
2016
Q4
$52.5M Buy
1,702,491
+288,309
+20% +$8.8M 0.79% 18
2016
Q3
$45.4M Sell
1,414,182
-1,257,240
-47% -$42M 0.8% 18
2016
Q2
$89.2M Buy
2,671,422
+1,516,571
+131% +$48.4M 1.82% 7
2016
Q1
$32.5M Buy
1,154,851
+138,999
+14% +$3.97M 0.85% 20
2015
Q4
$31.1M Buy
1,015,852
+94,190
+10% +$2.96M 0.8% 18
2015
Q3
$27.5M Buy
921,662
+26,282
+3% +$843K 0.78% 20
2015
Q2
$28.5M Buy
895,380
+40,216
+5% +$1.31M 0.6% 23
2015
Q1
$28.2M Buy
855,164
+42,057
+5% +$1.34M 0.53% 19
2014
Q4
$24M Buy
813,107
+24,990
+3% +$717K 0.48% 24
2014
Q3
$22.1M Buy
788,117
+71,174
+10% +$2M 0.46% 24
2014
Q2
$20.2M Buy
716,943
+549
+0.1% +$15.7K 0.44% 27
2014
Q1
$21.8M Buy
716,394
+115,324
+19% +$3.44M 0.53% 24
2013
Q4
$17.5M Buy
601,070
+22,320
+4% +$650K 0.46% 27
2013
Q3
$15.8M Buy
578,750
+265,167
+85% +$7.21M 0.47% 28
2013
Q2
$8.33M Buy
+313,583
New +$8.66M 0.87% 15

Other funds holding PFE

Janney Montgomery Scott's PFE Position: Q1 2026 in Review

Janney Montgomery Scott increased its Pfizer (PFE) stake by 5.4% in Q1 2026, buying an estimated $3.17M and bringing the position to 2,334,351 shares worth $65.5M. The position accounts for 0.16% of the portfolio, ranked #137.

Janney Montgomery Scott first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $142M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Janney Montgomery Scott held 2,334,351 shares of Pfizer worth $65.5M as of Q1 2026.
  • Janney Montgomery Scott bought 118,964 Pfizer shares in Q1 2026, an estimated $3.17M.
  • Pfizer made up 0.16% of Janney Montgomery Scott's portfolio in Q1 2026, its #137 holding.
  • Janney Montgomery Scott first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
  • Janney Montgomery Scott's Pfizer position peaked at $142M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.